| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.CBPA.2009.03.022 |
| P698 | PubMed publication ID | 19419901 |
| P2093 | author name string | Philip Stewart Low | |
| Sumith Anurasiri Kularatne | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 256-262 | |
| P577 | publication date | 2009-05-04 | |
| P1433 | published in | Current Opinion in Chemical Biology | Q15758415 |
| P1476 | title | Folate-targeted therapeutic and imaging agents for cancer | |
| P478 | volume | 13 |
| Q49797952 | 18F-AlF Labeled Peptide and Protein Conjugates as Positron Emission Tomography (PET) Imaging Pharmaceuticals. |
| Q91868661 | 18F-AzaFol for Detection of Folate Receptor-β Positive Macrophages in Experimental Interstitial Lung Disease-A Proof-of-Concept Study |
| Q91761770 | A Comprehensive Review on the Synthesis, Characterization, and Biomedical Application of Platinum Nanoparticles |
| Q33851549 | A Short-Term Biological Indicator for Long-Term Kidney Damage after Radionuclide Therapy in Mice |
| Q36320676 | A Targeted Nanoprobe Based on Carbon Nanotubes-Natural Biopolymer Chitosan Composites |
| Q26781856 | A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer |
| Q37588429 | A folate receptor-targeted lipoplex delivering interleukin-15 gene for colon cancer immunotherapy. |
| Q57183304 | A novel DAD type and folic acid conjugated fluorescent monomer as a targeting probe for imaging of folate receptor overexpressed cells |
| Q34302945 | A novel splice variant of folate receptor 4 predominantly expressed in regulatory T cells |
| Q34171642 | A pivotal role of vitamin B9 in the maintenance of regulatory T cells in vitro and in vivo |
| Q39065708 | Advancement of the Emerging Field of RNA Nanotechnology. |
| Q34413414 | Advances in the molecular design of potential anticancer agents via targeting of human telomeric DNA. |
| Q45348934 | Alginate-based microcapsules with a molecule recognition linker and photosensitizer for the combined cancer treatment |
| Q38990390 | An intracellularly activatable, fluorogenic probe for cancer imaging |
| Q38840381 | An unusual role of folate in the self-assembly of heparin-folate conjugates into nanoparticles |
| Q38955323 | An update on applications of nanostructured drug delivery systems in cancer therapy: a review |
| Q43971673 | Analysis of biomarker expression in severe endometriosis and determination of possibilities for targeted intraoperative imaging |
| Q35410329 | Apoptosis of HeLa cells induced by a new targeting photosensitizer-based PDT via a mitochondrial pathway and ER stress |
| Q35148819 | Application of a water-soluble pyridyl disulfide amine linker for use in Cu-free click bioconjugation |
| Q43639193 | Aptamer-targeted hyperbranched polymers: towards greater specificity for tumours in vivo. |
| Q38743029 | Bioconjugation and Applications of Amino Functional Fluorescence Polymers. |
| Q34194191 | Bioengineering strategies for designing targeted cancer therapies |
| Q26785463 | Biomarkers of Nutrition for Development-Folate Review |
| Q38227494 | Cancer active targeting by nanoparticles: a comprehensive review of literature. |
| Q35146922 | Cellular uptake and in vitro antitumor efficacy of composite liposomes for neutron capture therapy |
| Q36346851 | Challenges in design and characterization of ligand-targeted drug delivery systems |
| Q36654768 | Characterization of Folic Acid and Poly(amidoamine) Dendrimer Interactions with Folate Binding Protein: A Force-Pulling Study. |
| Q38436973 | Chemically Programmed Bispecific Antibodies in Diabody Format |
| Q36217175 | Chemically programmed bispecific antibodies that recruit and activate T cells |
| Q33862005 | Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells. |
| Q43535475 | Clinical significance of folate receptor β-expressing tumor-associated macrophages in pancreatic cancer |
| Q38015901 | Clinical translation of folate receptor-targeted therapeutics |
| Q47782730 | Co-coating of receptor-targeted drug nanocarriers with anti-phagocytic moieties enhances specific tissue uptake versus non-specific phagocytic clearance |
| Q36146218 | Comparison of Folate Receptor Targeted Optical Contrast Agents for Intraoperative Molecular Imaging |
| Q37109499 | Concordance of folate receptor-α expression between biopsy, primary tumor and metastasis in breast cancer and lung cancer patients |
| Q93186421 | Conventional and Chemically Programmed Asymmetric Bispecific Antibodies Targeting Folate Receptor 1 |
| Q35624762 | Dendrimer-based multivalent methotrexates as dual acting nanoconjugates for cancer cell targeting. |
| Q37383231 | Design and in vitro validation of multivalent dendrimer methotrexates as a folate-targeting anticancer therapeutic |
| Q35613117 | Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids |
| Q64949480 | Design of a ligand for cancer imaging with long blood circulation and an enhanced accumulation ability in tumors. |
| Q52686439 | Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo. |
| Q38716580 | Development of a New Folate-Derived Ga-68-Based PET Imaging Agent. |
| Q41197665 | Diseases originate and terminate by genes: unraveling nonviral gene delivery |
| Q52583647 | Distributions: The Importance of the Chemist's Molecular View for Biological Materials. |
| Q37335035 | Double-targeting using a TrkC ligand conjugated to dipyrrometheneboron difluoride (BODIPY) based photodynamic therapy (PDT) agent. |
| Q30362004 | Dual-targeted and pH-sensitive Doxorubicin Prodrug-Microbubble Complex with Ultrasound for Tumor Treatment. |
| Q37998528 | EC145: a novel targeted agent for adenocarcinoma of the lung |
| Q93133161 | Effect of Cationic Lipid Type in Folate-PEG-Modified Cationic Liposomes on Folate Receptor-Mediated siRNA Transfection in Tumor Cells |
| Q55215636 | Elimination of mouse tumor cells from neonate spermatogonial cells utilizing cisplatin-entrapped folic acid-conjugated poly(lactic-co-glycolic acid) nanoparticles in vitro. |
| Q30355707 | Emerging applications of porphyrins in photomedicine |
| Q41921148 | Engineered drug-protein nanoparticle complexes for folate receptor targeting |
| Q37029221 | Exploiting the co-reliance of tumours upon transport of amino acids and lactate: Gln and Tyr conjugates of MCT1 inhibitors |
| Q35832211 | Fc-Small Molecule Antibody Mimetics. |
| Q35738875 | Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer |
| Q42366884 | Folate Receptor-Positive Gynecological Cancer Cells: In Vitro and In Vivo Characterization |
| Q58585278 | Folate Receptor-Targeted and GSH-Responsive Carboxymethyl Chitosan Nanoparticles Containing Covalently Entrapped 6-Mercaptopurine for Enhanced Intracellular Drug Delivery in Leukemia |
| Q51019242 | Folate binding protein: therapeutic natural nanotechnology for folic acid, methotrexate, and leucovorin. |
| Q39108549 | Folate decorated magnetite nanoparticles: synthesis and targeted therapy against ovarian cancer |
| Q36413376 | Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma |
| Q55008640 | Folate receptor 1 (FOLR1) targeted chimeric antigen receptor (CAR) T cells for the treatment of gastric cancer. |
| Q37052124 | Folate receptor alpha (FRA) expression in breast cancer: identification of a new molecular subtype and association with triple negative disease |
| Q46028084 | Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy. |
| Q36050687 | Folate receptor alpha expression in lung cancer: diagnostic and prognostic significance |
| Q91833826 | Folate receptor-beta expression as a diagnostic target in human & rodent nonalcoholic steatohepatitis |
| Q34764419 | Folate receptor-mediated enhanced and specific delivery of far-red light-activatable prodrugs of combretastatin A-4 to FR-positive tumor |
| Q35225064 | Folate receptor-α (FOLR1) expression and function in triple negative tumors |
| Q37776257 | Folate-Targeted Therapies for Cancer |
| Q90185529 | Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter |
| Q38102935 | Folate-based radiotracers for PET imaging--update and perspectives. |
| Q51421010 | Folate-based single cell screening using surface enhanced Raman microimaging. |
| Q35047386 | Folate-chitosan-gemcitabine core-shell nanoparticles targeted to pancreatic cancer |
| Q35664403 | Folate-decorated nanogels for targeted therapy of ovarian cancer. |
| Q39149880 | Folate-mediated chemotherapy and diagnostics: An updated review and outlook |
| Q38872171 | Folic acid conjugated ferritins as photosensitizer carriers for photodynamic therapy |
| Q38826883 | Folic acid conjugated magnetic iron oxide nanoparticles for nondestructive separation and detection of ovarian cancer cells from whole blood |
| Q50475877 | Folic acid-conjugated 4-amino-phenylboronate, a boron-containing compound designed for boron neutron capture therapy, is an unexpected agonist for human neutrophils and platelets. |
| Q39237999 | Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery |
| Q36742449 | Folic acid-targeted iron oxide nanoparticles as contrast agents for magnetic resonance imaging of human ovarian cancer |
| Q92420913 | Formulation Strategies for Folate-Targeted Liposomes and Their Biomedical Applications |
| Q37689132 | Genetic and epigenomic footprints of folate |
| Q37200539 | Glucose conjugation for the specific targeting and treatment of cancer |
| Q36394209 | Gold nanorods for target selective SPECT/CT imaging and photothermal therapy in vivo |
| Q38189490 | Guiding principles in the design of ligand-targeted nanomedicines. |
| Q35948676 | High-permeability functionalized silicone magnetic microspheres with low autofluorescence for biomedical applications |
| Q38796801 | Identification of breast cancer margins using intraoperative near-infrared imaging |
| Q64057584 | Improving cellular uptake of therapeutic entities through interaction with components of cell membrane |
| Q42855261 | In Vivo Assay of Folate Receptors in Nonfunctional Pituitary Adenomas with 99mTc-Folate SPECT/CT |
| Q91428855 | In Vivo Evaluation of Ligand Targeted Drug Conjugates for Cancer Therapy |
| Q37594215 | Increased chemosensitivity and radiosensitivity of human breast cancer cell lines treated with novel functionalized single-walled carbon nanotubes |
| Q34127625 | Insight into nanoparticle cellular uptake and intracellular targeting |
| Q37933052 | Interfering with pH regulation in tumours as a therapeutic strategy |
| Q34751465 | Intracellular trafficking considerations in the development of natural ligand-drug molecular conjugates for cancer |
| Q39433611 | Intranuclear delivery of a novel antibody-derived radiosensitizer targeting the DNA-dependent protein kinase catalytic subunit |
| Q33808756 | Intraoperative Molecular Imaging of Lung Adenocarcinoma Can Identify Residual Tumor Cells at the Surgical Margins |
| Q37149571 | Intraoperative imaging in ovarian cancer: fact or fiction? |
| Q37528105 | Intraoperative molecular imaging to identify lung adenocarcinomas |
| Q38367036 | Involvement of autophagy in antitumor activity of folate-appended methyl-β-cyclodextrin |
| Q48268467 | Leukemia-specific delivery of mutant NOTCH1 targeted therapy. |
| Q30366990 | Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come. |
| Q33911056 | Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic |
| Q38806793 | Liposomal drug delivery systems for targeted cancer therapy: is active targeting the best choice? |
| Q37799613 | Liposomes targeting tumour stromal cells. |
| Q39103975 | MRI-visual order-disorder micellar nanostructures for smart cancer theranostics. |
| Q52659947 | Methods for construction and characterization of simple or special multifunctional RNA nanoparticles based on the 3WJ of phi29 DNA packaging motor. |
| Q35224467 | Multimodal bacteriochlorophyll theranostic agent. |
| Q90632896 | Nanogel: A Versatile Nano-Delivery System for Biomedical Applications |
| Q35019550 | Nanomedical engineering: shaping future nanomedicines |
| Q55091399 | Nanomedicine applications in women's health: state of the art. |
| Q33689872 | Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect |
| Q99712238 | Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance |
| Q49987235 | New mechanism for release of endosomal contents: osmotic lysis via nigericin-mediated K+/H+ exchange. |
| Q37411427 | Novel Use of Folate-Targeted Intraoperative Fluorescence, OTL38, in Robot-Assisted Laparoscopic Partial Nephrectomy: Report of the First Three Cases |
| Q58593068 | Novel solid-phase strategy for the synthesis of ligand-targeted fluorescent-labelled chelating peptide conjugates as a theranostic tool for cancer |
| Q91516516 | Optimization of Phase-Change Contrast Agents for Targeting MDA-MB-231 Breast Cancer Cells |
| Q35688131 | Photochemical release of methotrexate from folate receptor-targeting PAMAM dendrimer nanoconjugate. |
| Q45064469 | Platinum (IV) pro-drug conjugated NaYF4 :Yb(3+) /Er(3+) nanoparticles for targeted drug delivery and up-conversion cell imaging. |
| Q50242104 | Polyfluorene nanoparticles coated with folate-functionalized triblock copolymer: effective agents for targeted cell imaging |
| Q52707854 | Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment. |
| Q28087243 | Polymeric nanoparticles for targeted treatment in oncology: current insights |
| Q38167284 | Potential Use of Polyamidoamine Dendrimer Conjugates with Cyclodextrins as Novel Carriers for siRNA. |
| Q39205486 | Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent |
| Q39064107 | Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy |
| Q58910111 | Preparation and Characterization of Folate Targeting Magnetic Nanomedicine Loaded with Cisplatin |
| Q54336752 | Preparation and biological evaluation of (99m) TcN-labeled pteroyl-lys derivative as a potential folate receptor imaging agent. |
| Q91428807 | Preparation of Ligand-Targeted Drug Conjugates for Cancer Therapy and Their Evaluation In Vitro |
| Q39029672 | Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles |
| Q38210894 | Production and applications of engineered viral capsids |
| Q37193061 | Prospects in folate receptor-targeted radionuclide therapy |
| Q35041221 | Proteomic identification of mitochondrial targets of arginase in human breast cancer |
| Q92162442 | RNA Therapeutics: How Far Have We Gone? |
| Q98394652 | Radiosynthesis and preclinical evaluation of [68Ga]Ga-NOTA-folate for PET imaging of folate receptor β-positive macrophages |
| Q30436623 | Rational design for multifunctional non-liposomal lipid-based nanocarriers for cancer management: theory to practice. |
| Q89682756 | Recent Advances in Allogeneic CAR-T Cells |
| Q64897522 | Recent Advances in Degradable Hybrids of Biomolecules and NGs for Targeted Delivery. |
| Q37937611 | Recent advances in ligand targeted therapy |
| Q37015817 | Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides |
| Q59134586 | Regulatory Aspects of Oncologicals: Nanosystems Main Challenges |
| Q86753274 | Self-Assembling Nanoparticles of Amphiphilic Polymers for In Vitro and In Vivo FRET Imaging |
| Q38422536 | Shape matters: synthesis and biomedical applications of high aspect ratio magnetic nanomaterials. |
| Q38780383 | Small Molecules for Active Targeting in Cancer |
| Q35635607 | Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis |
| Q39215405 | Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles. |
| Q36369879 | Standardization and Optimization of Intraoperative Molecular Imaging for Identifying Primary Pulmonary Adenocarcinomas. |
| Q37690267 | Synthesis and Preclinical Evaluation of Folate-NOTA-Al(18)F for PET Imaging of Folate-Receptor-Positive Tumors |
| Q48139730 | Targeted Drug Delivery via Folate Receptors for the Treatment of Brain Cancer: Can the Promise Deliver? |
| Q89736507 | Targeted Nanomaterials for Phototherapy |
| Q34927053 | Targeted PDT agent eradicates TrkC expressing tumors via photodynamic therapy (PDT) |
| Q30472641 | Targeted nanoagents for the detection of cancers |
| Q89761451 | Targeting Tumors Using Peptides |
| Q44588616 | Targeting cancer cells with folic acid-iminoboronate fluorescent conjugates. |
| Q26744215 | Targeting folate receptor alpha for cancer treatment |
| Q91970512 | Targeting folate receptor β positive tumor-associated macrophages in lung cancer with a folate-modified liposomal complex |
| Q37562052 | The clinical potential of targeted nanomedicine: delivering to cancer stem-like cells |
| Q37210936 | The delivery of therapeutic oligonucleotides |
| Q39274501 | The first generation of β-galactosidase-responsive prodrugs designed for the selective treatment of solid tumors in prodrug monotherapy. |
| Q57045640 | The folate receptor β as a macrophage-mediated imaging and therapeutic target in rheumatoid arthritis |
| Q38176391 | The interaction of nanoparticles with plasma proteins and the consequent influence on nanoparticles behavior |
| Q64881075 | The nuclear export inhibitor aminoratjadone is a potent effector in extracellular-targeted drug conjugates. |
| Q33593665 | The smart targeting of nanoparticles |
| Q30881372 | The targeting behavior of folate-nanohydrogel evaluated by near infrared imaging system in tumor-bearing mouse model |
| Q92753705 | Therapeutic Potential of 47Sc in Comparison to 177Lu and 90Y: Preclinical Investigations |
| Q37302203 | Tissue distribution and tumor uptake of folate receptor-targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration |
| Q37983841 | Trafficking of intracellular folates |
| Q38191832 | Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy |
| Q47964947 | Ultrasound-Triggered Destruction of Folate-Functionalized Mesoporous Silica Nanoparticle-Loaded Microbubble for Targeted Tumor Therapy |
| Q39536450 | Unnatural amino acid incorporation onto adenoviral (Ad) coat proteins facilitates chemoselective modification and retargeting of Ad type 5 vectors |
| Q38255359 | Versatile carboxymethyl chitin and chitosan nanomaterials: a review |
| Q34276503 | Vinyl-triphenylamine dyes, a new family of switchable fluorescent probes for targeted two-photon cellular imaging: from DNA to protein labeling |
| Q34377276 | pH-(low)-insertion-peptide (pHLIP) translocation of membrane impermeable phalloidin toxin inhibits cancer cell proliferation |
Search more.